Related Experiment Video
Updated: Jun 8, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
A patient-centric chest pain management approach utilizing a high sensitivity Troponin-I assay
Abby E Roetger1, Christopher D McKinney2, De B Winter Iii3
1Institute of Safety and Quality, Novant Health, Wilmington, N.C., USA.
Insights
Implementing a new high-sensitivity troponin I (hs-cTnI) pathway in the emergency department improved efficiency for chest pain patients. This standardized approach demonstrated safety with no increase in major adverse cardiac events.
Area of Science:
- Cardiology
- Emergency Medicine
- Clinical Pathway Development
Background:
- Evaluating patients with chest pain in the emergency department (ED) requires efficient and accurate diagnostic tools.
- Traditional troponin assays and non-standardized approaches can lead to variable patient disposition and resource utilization.
Purpose of the Study:
- To assess the impact of adopting a new cardiac chest pain pathway incorporating high-sensitivity troponin I (hs-cTnI) testing in the ED.
- To evaluate the effect of this standardized pathway on patient disposition, length of stay, and clinical outcomes.
Main Methods:
- A retrospective observational study compared patients presenting with chest pain before and after the implementation of a new pathway.
- The new pathway included hs-cTnI testing (Seimens Healthineers Atellica) and risk stratification tools.
- Bivariate analyses compared outcomes, including discharge disposition, length of stay, and cardiac catheterization rates.
Main Results:
- The proportion of patients discharged from the ED increased, while observation or in-patient admissions decreased.
- Provider variation in patient disposition reduced, and stress testing rates for observed patients decreased.
- No significant change in 30-day Major Adverse Cardiac Events (MACE) was observed, but the 30-day Myocardial Infarction (MI) rate decreased.
Conclusions:
- The new standardized hs-cTnI algorithm approach is safe, with no increase in 30-day MACE.
- This pathway is more appropriate and efficient for evaluating chest pain patients in the ED compared to previous non-standardized methods.
Objective:
The purpose of this study was to assess the impact of adoption of a new cardiac chest pain pathway that included hs-cTnI in the emergency department (ED) when evaluating chest pain patients.
Methods:
A new pathway incorporating both hs-cTnI testing (Seimens Healthineers Atellica) and risk stratification tools was developed. The impact of the new algorithm was assessed through a retrospective observational review of patients admitted to the ED with chest pain before implementation and after implementation. Before implementation, the conventional Seimens troponin Vista assay was utilized without a defined algorithmic approach. Bivariate analyses were performed comparing the time periods to determine differences in patient discharge dispositions, length of stay, outcomes, and rate of diagnostic cardiac catheterization.
Results:
The proportion of patients discharged from the ED increased while the proportion of patients placed in observation or admitted as in-patient decreased. Variation amongst providers regarding patient disposition decreased. The stress testing rate of patients placed in observation decreased over baseline. There was no change in 30-day MACE rate, but there was a decrease in 30-day MI rate.
Conclusions:
The new standardized hs-cTnI algorithm approach is safe as demonstrated by no change in 30-day MACE and is also more appropriate and efficient for patients presenting to the ED with chest pain compared to the non-standardized approach with cTnI used previously.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
Related Concept Videos
Pericarditis IV: Nursing Management
Pericarditis II: Clinical features and Diagnostic Tests
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Myocarditis IV: Nursing Management